Cytokine expression, protection and shedding reduction induced by the combination of lipopolysaccharide with Montanoid ISA71 in oil-based Newcastle disease vaccine

• Published in: Microbial pathogenesis 2024-03, Vol.188, p.106542-106542, Article 106542
• Main Authors: Mahmoud, Nehal K., El-Deeb, Ayman H., Abd El-Khaleck, Mohamed A., Elsafty, Mounir M., Hussein, Hussein A.
• Format: Article
• Language: English
• Subjects: Combination; Cytokine genes expression; Depot; Egypt; endemic diseases; hemagglutination; interleukin-2; lipopolysaccharides; lymphocyte proliferation; Montanide™ ISA71 VG; Newcastle disease; pathogenesis; pathogenicity; phosphates; PRR; titration; transcription (genetics); vaccination; vaccines
• ISSN: 0882-4010; 1096-1208
• DOI: 10.1016/j.micpath.2024.106542

Oil-based inactivated ND vaccines are a commonly used control strategy for this endemic disease in Egypt. One of the major limitations of these inactivated vaccines is the time taken to develop a protective response in vaccinated birds. In the present study, we aimed to formulate an inactivated oil-based ND vaccine incorporated with lipopolysaccharide (LPS) that stimulates the early onset innate response to inactivated vaccines via proinflammatory cytokine production. Five groups of 21-day old SPF chicks were reared in isolators and were treated as follows: G1: Montanoid ISA71 adjuvanted NDV vaccinated group, G2: LPS and Montanoid ISA71 adjuvanted NDV vaccinated group, G3: LPS and Montanoid ISA71 with phosphate buffer saline received group and two non-vaccinated control groups. NDV specific antibodies and cell mediated immune responses were evaluated by hemagglutination inhibition and lymphocyte proliferation tests, respectively. Transcriptional responses of the TLR4, IFN-γ and IL-2 genes were analyzed in peripheral blood mononuclear cells (PBMCs) following vaccination by qRT-PCR. Protection % was determined after challenge with a lethal strain of NDV 106 EID50/0.5 ml. Viral shedding was assessed on oropharyngeal swabs by qRT-PCR and infectivity titration on SPF-ECE. The results revealed that the incorporation of LPS with ISA71 in the oil-based ND vaccine induced a synergistic response confirmed by significant humoral and lymphoproliferative responses with a significant increase in Th1 cytokine transcripts. The simultaneous use of both adjuvants in G2 demonstrated complete protection and a significant reduction in viral shedding compared to the ISA71-adjuvated ND vaccine in G1, which conferred 90 % protection. •The simultaneous use of LPS and ISA71 as adjuvants in oil-based ND vaccine upregulated INF-γ and IL-2 mRNA in chicken PBMCs.•The candidate vaccine achieved synergistic humoral and lymphoproliferative responses couldn't be obtained using ISA71 alone.•Absolute protection and remarkable reduction in NDV shedding were achieved by mixing such adjuvants with NDV antigen.